Filip Yabukarski
About Filip Yabukarski
Filip Yabukarski is a Senior Scientist in Structural Biology at Bristol Myers Squibb in the San Francisco Bay Area, with extensive experience in biochemistry, biophysics, and enzyme catalysis.
Title and Current Role
Filip Yabukarski serves as a Senior Scientist in Structural Biology at Bristol Myers Squibb. He is located in the San Francisco Bay Area, contributing to structural biology initiatives at this renowned biopharmaceutical company.
Work Experience
Filip Yabukarski has held various positions across esteemed institutions. He worked at Chan Zuckerberg Biohub as Scientist, Protein Sciences, from 2020 to 2022 in Stanford. Prior to that, he was a Consultant at Biotech Connection - Bay Area, Inc. in 2019. He co-founded ViRelieve, serving from 2018 to 2020. Additionally, Yabukarski was a Partner, Biotech Investments at Mythos Biotechnology Fund from 2018 to 2021 in Stanford. He also has a significant tenure as Staff Research Scientist, Enzymology & Structural Biology at Stanford University School of Medicine from 2014 to 2020. His earlier postdoctoral research was conducted at Unit of Virus Host Cell Interactions from 2010 to 2014 in Région de Grenoble, France.
Educational Background
Filip Yabukarski holds a Master's Degree in Structural Biology and Biochemistry from Université Grenoble Alpes, earned between 2008 and 2010. He also achieved a master's degree from FEG during the same period. Earlier, he completed a Licence in Biochemistry from Université de Bordeaux between 2006 and 2008 and another Licence from the same university from 2005 to 2006.
Expertise and Skills
Filip Yabukarski's expertise includes virus replication and enzyme catalysis. He is skilled in biochemistry, biophysics, and catalysis, and enjoys designing, carrying out, and analyzing research projects. His broad scientific experience enables him to develop new approaches to solve complex problems in biology.